FDA Grants Full Approval Of Deciphera Pharmaceuticals' QINLOCK™ (ripretinib) For The Treatment Of Fourth-Line Gastrointestinal Stromal Tumor

Margaret von Mehren, MD

Press/Media

Period	May 15 2020 → May 16 2020

Media coverage

22

Media coverage

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Spoke.com
Country/Territory	United States
Date	05/16/20
URL	www.spoke.com/press_releases/5ebf353030b352c10000f9f4
Persons	Margaret von Mehren

Title	FDA Grants Full Approval Of Deciphera Pharmaceuticals' QINLOCK™ (ripretinib) For The Treatment Of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	TheStreet.com
Country/Territory	United States
Date	05/15/20
URL	https://www.thestreet.com/press-releases/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-trade-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor-15323959
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals' QINLOCK(TM) (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor; -QINLOCK Significantly Improved Progression-Free Survival and Showed Clinically Meaningful Overall Survival in
Media name/outlet	Business Wire
Country/Territory	United States
Date	05/15/20
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Morningstar.com
Country/Territory	United States
Date	05/15/20
URL	https://www.morningstar.com/news/business-wire/20200515005575/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	BioSpace
Country/Territory	United States
Date	05/15/20
URL	https://www.biospace.com/article/releases/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor/?s=74
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	StocksNewsFeed.com
Country/Territory	United States
Date	05/15/20
URL	https://stocksnewsfeed.com/businesswire/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor/
Persons	Margaret von Mehren

Title	DECIPHERA PHARMACEUTICALS : FDA Grants Full Approval of Deciphera Pharmaceuticals' QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	05/15/20
URL	https://www.marketscreener.com/DECIPHERA-PHARMACEUTICALS-37892977/news/Deciphera-Pharmaceuticals-FDA-Grants-Full-Approval-of-Deciphera-Pharmaceuticals-QINLOCK-trade-r-30617667/
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceu...
Media name/outlet	ADVFN Deutschland
Country/Territory	Germany
Date	05/15/20
URL	https://de.advfn.com/p.php?pid=nmona&article=82473475
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals ’ QINLOCK ™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Stockwatch
Country/Territory	Canada
Date	05/15/20
URL	www.stockwatch.com/News/Item?bid=U-b20200515005575-U%3aDCPH-20200515&symbol=DCPH&region=U
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Market Newsdesk
Country/Territory	United States
Date	05/15/20
URL	www.marketnewsdesk.com/?p=270825
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Wallstreet Online
Country/Territory	Germany
Date	05/15/20
URL	https://www.wallstreet-online.de/nachricht/12533557-fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Crwe World
Country/Territory	United States
Date	05/15/20
URL	crweworld.com/article/news-provided-by-business-wire/1537066/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Jotup
Country/Territory	United States
Date	05/15/20
URL	https://jotup.co/node/782574
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Acrofan
Date	05/15/20
URL	https://us.acrofan.com/detail.php?number=282520
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	CIT
Country/Territory	United States
Date	05/15/20
URL	www.businesswire.com/news/home/20200515005575/en/FDA-Grants-Full-Approval-Deciphera-Pharmaceuticals%E2%80%99-QINLOCK%E2%84%A2/
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Deciphera Pharmaceuticals
Country/Territory	United States
Date	05/15/20
URL	https://investors.deciphera.com/news-releases/news-release-details/fda-grants-full-approval-deciphera-pharmaceuticals-qinlocktm
Persons	Margaret von Mehren

Title	Deciphera Pharmaceuticals Inc: FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor (Businesswire)
Media name/outlet	Avanza Bank AB
Country/Territory	Sweden
Date	05/15/20
URL	https://www.avanza.se/placera/pressmeddelanden/2020/05/15/deciphera-pharmaceuticals-inc-fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor.html
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	VB Profiles
Country/Territory	United States
Date	05/15/20
URL	https://www.vbprofiles.com/press_releases/5ebf011994904926119b2979
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor »
Media name/outlet	Deciphera Pharmaceuticals
Country/Territory	United States
Date	05/15/20
URL	investors.deciphera.com/node/8376
Persons	Margaret von Mehren

Title	FDA Grants Full Approval Of Deciphera Pharmaceuticals' QINLOCK For Treatment Of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Chicago Board Options Exchange
Country/Territory	United States
Date	05/15/20
URL	www.cboe.com/news/market-news-story?storyid=043f5721-f196-ea11-812c-3ca82a0ba215
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Digital Media Net
Country/Territory	United States
Date	05/15/20
URL	dmnnewswire.digitalmedianet.com/2020/05/15/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor/?utm_source=rss&utm_medium=rss&utm_campaign=fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor
Persons	Margaret von Mehren

Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Media name/outlet	Central Charts
Country/Territory	France
Date	05/15/20
URL	https://www.centralcharts.com/en/news/2647030-fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor
Persons	Margaret von Mehren